跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VAXAR 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VAXAR 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
VAXAR 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Adamed Laboratorios S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 26, 2021
Approval ID
350776857b8620bb
Company
Adamed Laboratorios S.L.U.
Type
Standard
Approval Details
Approval Id
350776857b8620bb
Drug Cima Aemps Name
VAXAR 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86108
Holder Company Name
Adamed Laboratorios S.L.U.
Marketing Company Name
Adamed Laboratorios S.L.U.
Authorization Date
2021-07-26
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
Yes
Company Name
Adamed Laboratorios S.L.U.
Active Ingredients
ROSUVASTATINA CALCICA
20,8 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 26, 2021
Approval ID
350776857b8620bb
Type
Standard
Back to CIMA-AEMPS Approvals